You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 11, 2025

List of Excipients in API ramipril


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing ramipril

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Pfizer Laboratories Div Pfizer Inc ALTACE ramipril 61570-110 FERRIC OXIDE YELLOW
Pfizer Laboratories Div Pfizer Inc ALTACE ramipril 61570-110 GELATIN
Pfizer Laboratories Div Pfizer Inc ALTACE ramipril 61570-110 STARCH, CORN
Pfizer Laboratories Div Pfizer Inc ALTACE ramipril 61570-110 TITANIUM DIOXIDE
Metacel Pharmaceuticals LLC VOSTALLY ramipril 69528-303 CITRIC ACID MONOHYDRATE
Metacel Pharmaceuticals LLC VOSTALLY ramipril 69528-303 ETHYLPARABEN
Metacel Pharmaceuticals LLC VOSTALLY ramipril 69528-303 METHYLPARABEN
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Get Started Free

Excipients in ANDA-approved (generic) drugs containing ramipril

Company Ingredient NDC Excipient
Hikma Pharmaceuticals USA Inc ramipril 0054-0106 D&C YELLOW NO. 10
Hikma Pharmaceuticals USA Inc ramipril 0054-0106 FD&C BLUE NO. 2
Hikma Pharmaceuticals USA Inc ramipril 0054-0106 FD&C RED NO. 40
Hikma Pharmaceuticals USA Inc ramipril 0054-0106 FD&C YELLOW NO. 6
Hikma Pharmaceuticals USA Inc ramipril 0054-0106 FERROSOFERRIC OXIDE
Hikma Pharmaceuticals USA Inc ramipril 0054-0106 GELATIN
Hikma Pharmaceuticals USA Inc ramipril 0054-0106 PROPYLENE GLYCOL
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Get Started Free

Detailed excipient profiles for ramipril

Excipient focus: ALCOHOL

Excipient focus: AMMONIA

Excipient focus: ANHYDROUS LACTOSE

Excipient focus: BUTYL ALCOHOL

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CI 16035

Excipient focus: CI 77499

Excipient focus: CITRIC ACID MONOHYDRATE

Excipient focus: D&C RED NO. 28

Excipient focus: D&C RED NO. 33

Excipient focus: D&C YELLOW NO. 10

Excipient focus: ETHYLPARABEN

Excipient focus: FD&C BLUE NO. 1

Excipient focus: FD&C BLUE NO. 2

Excipient focus: FD&C RED NO. 3

Excipient focus: FD&C RED NO. 40

Excipient focus: FD&C YELLOW NO. 5

Excipient focus: FD&C YELLOW NO. 6

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: FERROSOFERRIC OXIDE

Excipient focus: GELATIN

Excipient focus: HYPROMELLOSES

Excipient focus: INDIGOTINDISULFONATE SODIUM

Excipient focus: ISOPROPYL ALCOHOL

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: MAGNESIUM OXIDE

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MEGLUMINE

ramipril drug variants containing MEGLUMINE

Company Ingredient NDC
A-S Medication Solutions ramipril 50090-3059
A-S Medication Solutions ramipril 50090-4597
A-S Medication Solutions ramipril 50090-4691
Northwind Pharmaceuticals LLC ramipril 51655-144
Northwind Pharmaceuticals LLC ramipril 51655-346
Northwind Pharmaceuticals LLC ramipril 51655-347
Lake Erie Medical DBA Quality Care Products LLC ramipril 55700-551
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: METHYLPARABEN

Excipient focus: PEPPERMINT

Excipient focus: POTASSIUM HYDROXIDE

Excipient focus: PROPYLENE GLYCOL

Excipient focus: SHELLAC

Excipient focus: SILICA

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: SODIUM STEARYL FUMARATE

Excipient focus: STARCH, CORN

Excipient focus: STARCH, PREGELATINIZED CORN

Excipient focus: SUCRALOSE

Excipient focus: TITANIUM DIOXIDE

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
 NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links